Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 16,084 shares at $28.06 ($451K) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Open-market sale of $451k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.06 | 7,499 | $210K | 46.6% |
| 2 | $28.06 | 7,499 | $210K | 46.6% |
| 3 | $28.26 | 225 | $6K | 1.4% |
| 4 | $28.00 | 861 | $24K | 5.3% |
| Total | $28.06 avg | 16,084 | $451K | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |